Hosted on MSN

Cabaletta Bio’s treatment of myasthenia gravis granted FDA orphan designation

Cabaletta Bio’s (CABA) treatment of myasthenia gravis, resecabtagene autoleucel, was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...
CNET

At CES 2026, Gbrain's Phin Stim Signals a New Era for Implantable Brain Therapy

I spoke with neuroscientists from an Incheon, Korea-based startup that's looking to minimize the symptoms of epilepsy or Parkinson's disease.
Investing

ImmunityBio reports promising 3-year bladder cancer treatment data

According to the company’s press release statement, these results could potentially change the treatment paradigm for patients with this condition. In other recent news, ImmunityBio has received a ...
Nature

Integrating Biological Early Warning Systems with High-Resolution Online Chemical Monitoring in Wastewater Treatment Plants

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
mccormick.northwestern.edu

Biohybrid Systems for Better Living

A wearable sensor system that predicts fatigue at work. A tiny implant that delivers diabetes drugs on demand. A flexible patch that optimizes the sense of touch for the visually impaired. Through the ...